(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Raffles City Convention Centre

Jan 28, 2013 7:00 AM - Jan 30, 2013 5:00 PM

252 , North Bridge Road, Singapore 179103, Singapore

Asia Regulatory Conference 2013

Back to Agenda

Session 2: Path to the Future: Status and Future of Research and Development

Session Chair(s)

Yves Juillet, DIAFellow, MD

Yves Juillet, DIAFellow, MD

Secretary General , Académie De Médecine, France

Science is constantly moving forward. Implementing these new concepts or even creating them in drug Research and Development is key. It implies for Regulatory Authorities and Industry researchers a permanent adaptation to these new paradigms thanks to the development of Regulatory Science.

Speaker(s)

Murray M. Lumpkin, DrMed, MD, MSC

Murray M. Lumpkin, DrMed, MD, MSC

Deputy Director, Integrated Development, Lead for Global Reg Systems Initiative , Bill and Melinda Gates Foundation, United States

Advancing the Science of Medicines Regulation: The Role of the 21st Century Medicines Regulator

James Garner, MA, MBA

James Garner, MA, MBA

Vice President & General Manager, Takeda Global Research & Development Center (Asia), Singapore

Speaker

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.